GlycoNex Incorporation (4168.TWO)
TWD 17.55
(-5.14%)
TWD 17.55
(-5.14%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.54 Million TWD | -91.55% |
| 2022 | 30.08 Million TWD | 449.5% |
| 2021 | 5.47 Million TWD | 1113.97% |
| 2020 | 451 Thousand TWD | -38.56% |
| 2019 | 734 Thousand TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 9.23 Million TWD | 0.0% |
| 2024 Q2 | 95 Thousand TWD | -98.97% |
| 2023 Q2 | 1.4 Million TWD | 600.5% |
| 2023 Q4 | - TWD | -100.0% |
| 2023 Q3 | 933 Thousand TWD | -33.74% |
| 2023 FY | 2.54 Million TWD | -91.55% |
| 2023 Q1 | 201 Thousand TWD | -87.82% |
| 2022 Q4 | 1.65 Million TWD | 0.0% |
| 2022 FY | 30.08 Million TWD | 449.5% |
| 2021 FY | 5.47 Million TWD | 1113.97% |
| 2020 FY | 451 Thousand TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 99.772% |
| Level Biotechnology Inc. | 660.61 Million TWD | 99.615% |
| TaiMed Biologics Inc. | 491.77 Million TWD | 99.483% |
| GeneReach Biotechnology Corp. | 225.46 Million TWD | 98.873% |
| OBI Pharma, Inc. | 41.54 Million TWD | 93.882% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 99.196% |
| Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 99.358% |
| Visgeneer Inc. | 147.99 Million TWD | 98.282% |
| Neith Corporation | 39.9 Million TWD | 93.63% |
| Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 95.534% |
| Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 99.348% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | 88.822% |
| Enimmune corporation | 43.49 Million TWD | 94.156% |
| TaiRx, Inc. | 5.08 Million TWD | 49.98% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 99.04% |
| Sunny Pharmtech Inc. | 428.82 Million TWD | 99.407% |
| Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 99.665% |
| Feng Chi Biotech Corp. | 180.57 Million TWD | 98.592% |
| Lukas Biomedical Inc. | 231.83 Million TWD | 98.904% |
| RBC Bioscience Corporation | 172.46 Million TWD | 98.526% |
| NaviFUS Corp. | 22.48 Million TWD | 88.693% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -2724.444% |
| Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | 73.31% |
| Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | 47.588% |
| Sagittarius Life Science Corp | 440.46 Million TWD | 99.423% |
| Bio Preventive Medicine Corp. | 1.2 Million TWD | -110.43% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 97.687% |
| G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 98.599% |
| Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -215.776% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -249.176% |
| AP Biosciences Inc | 32.25 Million TWD | 92.119% |
| Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 99.849% |
| Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 99.862% |
| EirGenix Inc. | 1.02 Billion TWD | 99.751% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 99.192% |
| Mycenax Biotech Inc. | 652.62 Million TWD | 99.61% |
| SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | 87.413% |
| Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
| NeoCore Technology Co., Ltd. | 64.72 Million TWD | 96.073% |
| VBI | 55.85 Million TWD | 95.449% |
| BiOptic Inc. | 228.26 Million TWD | 98.886% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 98.199% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 99.682% |
| Medigen Biotechnology Corp. | 1.15 Billion TWD | 99.78% |
| 3D Global Biotech Inc. | 20.63 Million TWD | 87.68% |
| Intech Biopharm Corporation | 25.84 Million TWD | 90.165% |
| Oneness Biotech Co., Ltd. | 86.78 Million TWD | 97.071% |
| TWi Biotechnology, Inc. | - TWD | -Infinity% |
| TCI GENE Inc. | 333.85 Million TWD | 99.239% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -14022.222% |
| Senhwa Biosciences, Inc. | 1 Million TWD | -154.2% |
| Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 97.026% |
| NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 98.413% |
| PharmaEngine, Inc. | 767.66 Million TWD | 99.669% |
| Savior Lifetec Corporation | 1.05 Billion TWD | 99.758% |
| TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 97.936% |
| Meribank Biotech Co., Ltd | 234.34 Million TWD | 98.915% |
| Acepodia, Inc. | 16.59 Million TWD | 84.68% |
| Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | 93.471% |